{"name":"N&N Pharmaceuticals Inc.","slug":"n-n-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"N-Methanocarbathymidine","genericName":"N-Methanocarbathymidine","slug":"n-methanocarbathymidine","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"N-Methanocarbathymidine","genericName":"N-Methanocarbathymidine","slug":"n-methanocarbathymidine","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0wJBVV95cUxOcDV1bXk0b2gyTWJ4NFpEWC1pTmpwYm1LU2ZtTVB4U0dkWDg0b1llZXNxR2NDRGlzTEd3VThJSG8xR0FscmlGNnF3dWc4TjRxN1RmX0FjTXppTXBkNUoycHIxeDk5SWhENEpLMk1IVWZSZHlDblhxOVBDVzFJcGZaSFRCUV85T1ZMejRucWdwWExDTTBremRJX2hjUTZOVkdpYkNLN0VrZFhZQ2xRNm9IVXBydG1VdWR4SkVKU3dYU0RMUVJURllZbDBGcVZ6ajVQS29DbkR5X3ozSHNlanBSMmpKcFV0Y3JuaFBIVXZva1FkYVNvN3BlRllaakpnU243YXZEZmJKYnh4TVFwOHpBWm1NSnp2ZXR3cFZZMnN4ZUpQT2phUllObktIYWpFYTVqb204Wms3WjRMbUVpYlNwZGg1RDhHNHVrS1VTMEdmX25MVEU?oc=5","date":"2025-03-05","type":"regulatory","source":"PR Newswire","summary":"Novo Nordisk introduces NovoCare® Pharmacy, lowering cost of all doses of FDA-approved Wegovy® (semaglutide) to $499 per month and offering easy home delivery for cash-paying patients - PR Newswire","headline":"Novo Nordisk introduces NovoCare® Pharmacy, lowering cost of all doses of FDA-approved Wegovy® (semaglutide) to $499 per","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTFBfQU0yWFhvMW5nY0NOS1hkVmxoVDh6RlJXa09PQ0lxUGx1WGxjUmtOdTZQRGl5eFVGT2NEemxrT0ZyWDRRTzZWN0Nmc3ZrRm8?oc=5","date":"2025-02-13","type":"pipeline","source":"Parliament.mn","summary":"Parliamentary working group reviews food and pharmaceutical safety in Darkhan-Uul - Parliament.mn","headline":"Parliamentary working group reviews food and pharmaceutical safety in Darkhan-Uul","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNdDR1ajQ0aGpQZ3N5aWtSNFc0RTRGaV9kRl9ON2wzQlA5WkJKaW12N001V2NPdlJ2ZC16dmp2eDliNEt6czJuZ3gzZjNEY1NjakllTGxZdHdObU14M3hMQ1FIN3VtMVFxTXVkZ0cxYW93ZU43NlZHN3JuTkdscXlIN2tZZ2ZIWUt5SWhSYnlNM3BtcFRFT3VRS1ZDUFFJaGlUTkY3R2VCX0VnMzE1QVhiR3FlV0g?oc=5","date":"2024-12-18","type":"pipeline","source":"Fierce Biotech","summary":"Novo Nordisk taps Photys for $186M cardiometabolic collab - Fierce Biotech","headline":"Novo Nordisk taps Photys for $186M cardiometabolic collab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE84bEJQbUJIeHNfSGI4M1Z6UWpzbVVRb3V2TVI0elV1czBPU1JmM0tWbXBUazRSSXBhSDQ4NURkSHVuSFY5WFhvMVZyUXNhQmZMN1VYUWtXS3BteENrMEs4dGE3Y3FCaWRp?oc=5","date":"2024-06-23","type":"pipeline","source":"Wiley Online Library","summary":"Fabrication, structural elucidation, and DFT calculation of some new hydrophilic metal chelates based on N N ′-(1-methyl-2-oxoindolin-3-ylidene)benzohydrazide ligand: Pharmaceutical studies and molecu","headline":"Fabrication, structural elucidation, and DFT calculation of some new hydrophilic metal chelates based on N N ′-(1-methyl","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNS1hpTm9MWTZFYzJ3Tmt4Y0pqMnZiRnJnWHkwT2xPNlVPWWxOT2oxcDBNUldLRGpmZWRZaWxPUjlxOUhVSDFUTTlpaTgta1BMdm1NRFBDT25GWXJTWDZ2MVQzWE5tQTFFQmkzYVVDRG0tZzh3OG9aM2dwcUdBT3RZVUFBMDM5SlZxOWw3VFpFaE54OHAxR2N0T3hlemdNalg3WEhkeEVmcWlvdEh6bURxdkliNktCZHljbnQ5S2dJY0dLY1dx?oc=5","date":"2023-06-12","type":"pipeline","source":"European Pharmaceutical Review","summary":"Novo Nordisk invests €2.1bn in Hillerød manufacturing expansion - European Pharmaceutical Review","headline":"Novo Nordisk invests €2.1bn in Hillerød manufacturing expansion","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}